Benaim Ely
Insider CIK 1632237 · RNN Chief Medical Officer · NVCR Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVCR NovoCure Ltd | A Award | 2023-01-06 | 2023-01-10 | 98 | $62.31 | $6.1K | 28,770 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-08-03 | 2022-08-04 | 5,396 | $74.00 | $399.3K | 28,672 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-08-03 | 2022-08-04 | 563 | $71.09 | $40.0K | 34,068 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-08-02 | 2022-08-03 | 437 | $69.66 | $30.4K | 34,631 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2022-07-05 | 2022-07-07 | 222 | $59.08 | $13.1K | 35,068 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-05-11 | 2022-05-12 | 2,135 | $61.25 | $130.8K | 34,846 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-05-10 | 2022-05-12 | 2,070 | $65.16 | $134.9K | 36,981 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-03-04 | 2022-03-07 | 1,510 | $70.41 | $106.3K | 43,257 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2022-03-03 | 2022-03-07 | 30,422 | $80.59 | $2.45M | 30,422 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2022-03-03 | 2022-03-07 | 5,452 | $80.59 | $439.4K | 5,452 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2022-03-03 | 2022-03-07 | 17,371 | — | $0 | 45,570 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-03-03 | 2022-03-07 | 803 | $74.50 | $59.8K | 44,767 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2022-01-06 | 2022-01-12 | 55 | $63.82 | $3.5K | 28,199 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-08-03 | 2021-08-04 | 464 | $150.11 | $69.7K | 28,144 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-08-02 | 2021-08-03 | 536 | $149.38 | $80.1K | 28,608 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-07-30 | 2021-08-03 | 651 | — | $0 | 3,253 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-07-30 | 2021-08-03 | 651 | $158.96 | $103.5K | 29,144 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-07-30 | 2021-08-03 | 651 | $83.30 | $54.2K | 29,795 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2021-07-06 | 2021-07-08 | 90 | $137.12 | $12.3K | 29,144 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-05-27 | 2021-05-28 | 1,833 | — | $0 | 7,332 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-05-27 | 2021-05-28 | 1,833 | $200.00 | $366.6K | 29,054 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-05-27 | 2021-05-28 | 1,833 | $47.56 | $87.2K | 30,887 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-05-12 | 2021-05-14 | 1,943 | $180.48 | $350.7K | 29,054 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-05-11 | 2021-05-12 | 2,262 | $180.12 | $407.4K | 30,997 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-05-10 | 2021-05-12 | 1,833 | — | $0 | 9,165 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-05-10 | 2021-05-12 | 1,833 | $47.56 | $87.2K | 35,092 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-05-10 | 2021-05-12 | 1,833 | $189.65 | $347.6K | 33,259 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-04-13 | 2021-04-15 | 3,474 | — | $0 | 19,404 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-04-13 | 2021-04-15 | 651 | — | $0 | 3,904 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-04-13 | 2021-04-15 | 1,833 | — | $0 | 10,998 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 651 | $200.00 | $130.2K | 33,259 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-04-13 | 2021-04-15 | 3,474 | $69.37 | $241.0K | 36,733 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-04-13 | 2021-04-15 | 1,833 | $47.56 | $87.2K | 35,092 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-04-13 | 2021-04-15 | 651 | $83.30 | $54.2K | 33,910 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,833 | $200.00 | $366.6K | 33,259 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 3,474 | $200.00 | $694.8K | 33,259 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-03-05 | 2021-03-09 | 2,918 | $131.53 | $383.8K | 33,259 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-03-04 | 2021-03-05 | 1,888 | $137.55 | $259.7K | 36,177 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-03-03 | 2021-03-05 | 3,475 | — | $0 | 22,878 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-03-03 | 2021-03-05 | 3,475 | $150.78 | $524.0K | 38,065 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-03-03 | 2021-03-05 | 3,475 | $69.37 | $241.1K | 41,540 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2021-03-02 | 2021-03-04 | 16,003 | — | $0 | 16,003 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2021-03-02 | 2021-03-04 | 8,709 | — | $0 | 38,065 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-12-21 | 2020-12-22 | 1,833 | — | $0 | 12,831 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-12-21 | 2020-12-22 | 651 | — | $0 | 4,555 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-12-21 | 2020-12-22 | 1,833 | $47.56 | $87.2K | 31,189 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-12-21 | 2020-12-22 | 1,833 | $156.71 | $287.2K | 29,356 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-12-21 | 2020-12-22 | 651 | $83.30 | $54.2K | 30,007 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-12-21 | 2020-12-22 | 651 | $156.71 | $102.0K | 29,356 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-08-03 | 2020-08-05 | 660 | $76.06 | $50.2K | 29,356 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-31 | 2020-08-03 | 341 | $76.39 | $26.0K | 30,016 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2020-07-07 | 2020-08-03 | 325 | $50.41 | $16.4K | 30,357 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-12 | 2020-05-14 | 2,595 | $64.78 | $168.1K | 12,616 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-11 | 2020-05-12 | 1,611 | $63.73 | $102.7K | 15,211 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-08 | 2020-05-12 | 4,206 | — | $0 | 8,410 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-08 | 2020-05-12 | 4,206 | $63.84 | $268.5K | 16,822 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2020-03-03 | 2020-03-05 | 27,794 | — | $0 | 27,794 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2020-03-03 | 2020-03-05 | 14,415 | — | $0 | 30,032 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-07-30 | 2019-08-01 | 5,206 | — | $0 | 5,206 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2019-07-30 | 2019-08-01 | 3,001 | — | $0 | 15,617 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,375 | — | $0 | 4,750 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2019-02-28 | 2019-03-01 | 2,375 | — | $0 | 4,750 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2019-01-25 | 2019-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-03-07 | 2018-03-09 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,375 | — | $0 | 7,125 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2018-02-28 | 2018-03-02 | 2,375 | — | $0 | 2,375 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-01-26 | 2018-01-30 | 45,443 | — | $0 | 45,443 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 95,000 | — | $0 | 95,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 450,000 | — | $0 | 450,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 98,734 | — | $0 | 98,734 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2015-02-02 | 2015-02-04 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |